China-based retail website VIPStore.com closed a series D funding round worth more than $20m yesterday, featuring Intel Capital among others, according to business and finance website China Knowledge. Also participating were China-based venture capital (VC) firms GSR Ventures and EZ Capital. VIPStore’s series C round fetched more than in $10m in January, and was led… Continue reading Intel: very important investor at VIPStore
Author: Robert Lavine
SAP goes to Right Hemisphere
Right Hemisphere will become the latest acquisition by SAP, which has been backing the 3-D software company since 2007 through its corporate venturing unit.
Vorwerk shops for a bargain with Pauldirekt
Pauldirekt has obtained funding as it looks to expand its customer base.
Harvest gathers up Coastal Supply
The renewable energy company acquires competitor Coastal Supply, after obtaining an extra $1.3m in funding four days before.
MTPV applies for further funding
US-based clean energy semiconductor developer MTPV closed its initial series B funding round yesterday at $6.5m, with a view to raising a further $2m in the round. Among the investors was Applied Ventures, the corporate venturing division of US-based semiconductor component manufacturer Applied Materials. Publicly funded agency The Massachusetts Clean Energy Center and venture capital… Continue reading MTPV applies for further funding
Clean Power attracts Google financing
Google Ventures, together with venture capital firm Kleiner Perkins Caufield Byers, has invested $19m in US-based clean technology software company Clean Power Finance. The investment was made on the 1st of September. Together with funding raised from venture capital (VC) firm Claremont Creek Ventures, and VC funds Clean Pacific Ventures and Sand Hill Angels, in… Continue reading Clean Power attracts Google financing
General Compression squeezes funding from investors
General Compression, which counts energy companies Duke and ConocoPhillips among its backers, has attracted more funding to take its series B round to $60m.
Chevron, Solon-backed Nimbus exits to Tibco
Business software company Nimbus sells to Tibco, after it was backed by Chevron and Solon in 2009.
Bosch helps Ident raise €7.1m
Robert Bosch Venture Capital (RBVC), the corporate venturing unit of the Germany-based consumer technology and automotive parts conglomerate, on Monday helped Germany-based near-field communication company Ident raise €7.1m ($10m). The round was joined by Danube Equity, the Austria-based corporate venturing unit formed by the steel corporation Voestalpine and the 3-Banken Group, a fund belonging to… Continue reading Bosch helps Ident raise €7.1m
Sun rises for Perfect World’s fund
China-based online game developer Perfect World yesterday established a venture capital fund, investing RMB643.5m ($100.7m). The fund will concentrate on the technology, media and telecommunications (TMT) sector. The fund will be formed by a subsidiary company owned by Perfect World, in conjunction with several as yet unnamed partner companies from outside. Perfect World’s investment will… Continue reading Sun rises for Perfect World’s fund
BGF takes well-traveled Rhodes
Jon Rhodes becomes the latest high-profile executive to join the fund, this time in a public relations role.
Intel-backed Gudeng goes public
The Taiwan-based Gudeng, which manufactures equipment for semiconductors, has become the third Intel Capital company to float this year.
CrunchFund time for Michael Arrington and AOL
Michael Arrington, the founder of the technology-focused business website TechCrunch, has resigned as editor of the AOL-owned site in order to found his own venture capital (VC) fund, to be known as CrunchFund, in conjunction with Patrick Gallagher, a partner at VantagePoint Capital Partners. Crunchfund closed its initial financing at $20m, with AOL Ventures as… Continue reading CrunchFund time for Michael Arrington and AOL
Neuropace gathers speed as it collects more funding
The Johnson & Johnson-backed medical device company has raised almost $50m in its latest round of funding, as clinical tests for its new system continue.